RISING PHARMACEUTICALS

FDA Regulatory Profile

Summary

Total Recalls
9
510(k) Clearances
0
Inspections
3
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0348-2023Class IIWarfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, SaFebruary 15, 2023
D-0573-2022Class IIMethylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for:February 7, 2022
D-0005-2022Class IIMeclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma HoldiSeptember 2, 2021
D-1367-2020Class IIITimolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in tNovember 15, 2019
D-1368-2020Class IIITimolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application, DistriNovember 15, 2019
D-1053-2019Class IIValsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC, SaddlMarch 7, 2019
D-1054-2019Class IIValsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC, SaddlMarch 7, 2019
D-1055-2019Class IIValsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, LLC, Saddle Brook, March 7, 2019
D-1052-2019Class IIValsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, SaddMarch 7, 2019